Shares in Novo Nordisk (NYSE: NVO) fell more than 4% following the market open on Friday after the Danish pharma giant released data from a phase 2a clinical trial with its obesity drug, monlunabant.

GETT Gold (TSXV:GETT), a junior gold miner and service provider active in Quebec, revealed that its mining equipment suffered ...

A private bank employee in Vadodara has been arrested for allegedly aiding cyber criminals by opening bank accounts used in fraudulent activities. The investigation reveals a pattern of negligence in ...

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...